Type: Ingredient entity — regulatory & claim record
Topic: Retinyl Palmitate (레티닐팔미테이트) — cosmetic ingredient
Evidence basis: MFDS functional-cosmetic notification (기능성화장품 심사에 관한 규정 별표4, 고시 제2025-88호), PubChem chemical identity
Last Verified: 2026-07-13
This page does not make treatment, disease prevention, or efficacy claims. See the Evidence Boundaries section.
Retinyl Palmitate (Korean: 레티닐팔미테이트) is recorded here as a functional-cosmetic ingredient within Korea’s regulatory framework. It appears on the Ministry of Food and Drug Safety (MFDS) list of ingredients whose efficacy data may be omitted for a functional cosmetic — specifically under the “wrinkle improvement” category of Annex 4 of the Regulation on the Review of Functional Cosmetics (고시 제2025-88호).
Being on this list means the regulator has predefined an approved ingredient, a maximum content, and a fixed efficacy phrase for wrinkle improvement products. It does not describe how well the ingredient works, nor does it authorize any wording beyond the notified phrase. This page organizes what the notification actually states, and where the boundary of that statement lies.
Retinyl Palmitate is used in cosmetic formulations in the wrinkle improvement category. Under the notification, its permitted content is 10,000 IU/g, and its use is limited to lotion, liquid, cream, and sheet-mask (침적 마스크) product forms.
Ingredient Snapshot
| Field | Value |
|---|---|
| Ingredient Name | Retinyl Palmitate |
| Korean Name | 레티닐팔미테이트 |
| INCI Name | Retinyl Palmitate |
| Synonyms | Vitamin A palmitate; Retinol palmitate |
| CAS No. | 79-81-2 |
| Molecular Formula | C36H60O2 |
| Ingredient Type | Functional cosmetic ingredient |
| Cosmetic Role | wrinkle improvement (기능성 — 주름개선) |
| Supplement Function | Unknown / Not applicable |
| Status | To Review |
Chemical identity (CAS 79-81-2, molecular formula C36H60O2, PubChem CID 5280531) and the INCI name are from PubChem.
Regulatory Records
| Record Type | Jurisdiction | Issuing Body | Record Number | Scope | Status | Source |
|---|---|---|---|---|---|---|
| Functional cosmetic notification (별표4 고시원료) | Korea (KR) | MFDS (식품의약품안전처) | 고시 제2025-88호 | Annex 4, item 3 (wrinkle improvement) — 성분명 레티닐팔미테이트 / 함량 10,000IU/g; forms limited to lotion, liquid, cream, sheet mask | Active / To Review | MFDS 별표4 (law.go.kr) |
Directly verified against the notification text (별표4 제3호 주름개선). The notified efficacy phrase for this wrinkle improvement category is “피부의 주름개선에 도움을 준다” (“helps improve skin wrinkles”).
Claim Safety Matrix
⚠️ Claim classification below reflects the DB record and requires human regulatory review before publication.
| Claim Text | Claim Type | Why It Matters | Safer Alternative Wording | Source |
|---|---|---|---|---|
| “피부의 주름개선에 도움을 준다” (“helps improve skin wrinkles”), at 10,000 IU/g content in the specified product forms | Allowed | This is the exact efficacy phrase the notification fixes for the wrinkle improvement category. It is permitted only at the notified content (10,000 IU/g) and product forms; the wording itself is defined by the regulator, not chosen by the marketer. | Use the notified phrase verbatim: “피부의 주름개선에 도움을 준다.” | MFDS 고시 제2025-88호 별표4 |
| “주름 제거” / “안티에이징” / “리프팅” / “콜라겐 생성” (“wrinkle removal / anti-aging / lifting / collagen synthesis”) | Avoid | The notified efficacy is limited to “helps improve skin wrinkles.” Removal, anti-aging, lifting, or collagen-synthesis wording exceeds the notified wrinkle-improvement phrase. | Replace with the notified phrase “피부의 주름개선에 도움을 준다.” | MFDS 고시 제2025-88호 별표4 (efficacy scope limit) |
Evidence Boundaries: What This Page Does Not Claim
The following claims are outside the scope of this ingredient record:
No disease treatment or prevention. The notification defines a cosmetic wrinkle improvement function only; it does not support treating or preventing any skin disease or disorder.
No drug-like efficacy. Removal, anti-aging, lifting, or collagen-synthesis wording exceeds the notified wrinkle-improvement phrase. Such wording implies a pharmaceutical or complete-effect claim that exceeds the notified phrase and is not supported here.
No guaranteed or individual results. Regulatory listing predefines an approved phrase and content; it does not measure or guarantee any individual outcome.
No content or efficacy beyond the notification. Content above 10,000 IU/g or product forms outside the notified list (lotion, liquid, cream, sheet mask) fall outside this record.
Related Entities
Related Ingredients
- Retinol — related retinoid, notified wrinkle-improvement ingredient
- Adenosine — notified wrinkle-improvement ingredient
- MFDS 별표4 wrinkle-improvement category ingredients
Related Product Types
- Functional wrinkle improvement cosmetics (기능성화장품 — 주름개선): lotion, liquid, cream, sheet mask
Related Claims
- Notified wrinkle improvement efficacy phrase (“피부의 주름개선에 도움을 준다”)
- Efficacy-scope boundary (stronger/medical wording excluded)
Related Regulatory Concepts
- 기능성화장품 (functional cosmetics) — Annex 4 data-omission list
- MFDS 고시 제2025-88호 (Regulation on the Review of Functional Cosmetics)
Source Transparency Note
This page uses the following source classification:
| Source | Role | Authority Scope | Limit |
|---|---|---|---|
| MFDS 고시 제2025-88호 (별표4) | Regulatory | Approved wrinkle improvement ingredient, notified content (10,000 IU/g), fixed efficacy phrase | 화장품 한정 — 효능 정도·개인별 결과는 규정하지 않음 |
| PubChem | Chemical identity | CAS No. 79-81-2, molecular identity (CID 5280531) | 규제·claim 근거 아님 |
KCIA is used for naming/synonym confirmation only and is not used as the basis for any functional or medical claim.
Frequently Asked Questions
Is Retinyl Palmitate a regulated cosmetic ingredient in Korea?
Yes. Retinyl Palmitate is listed by the MFDS in Annex 4 of the Regulation on the Review of Functional Cosmetics (고시 제2025-88호) as a wrinkle improvement ingredient whose efficacy data may be omitted, at a notified content of 10,000 IU/g.
What wrinkle improvement claim is allowed for Retinyl Palmitate in Korean cosmetics?
The notification fixes the efficacy phrase “helps improve skin wrinkles” (피부의 주름개선에 도움을 준다) for this category. Retinyl Palmitate products should use this notified wording rather than stronger claims.
Can Retinyl Palmitate claims mention disease treatment?
No. Removal, anti-aging, lifting, or collagen-synthesis wording exceeds the notified wrinkle-improvement phrase. Such wording exceeds the notified wrinkle improvement phrase for Retinyl Palmitate and is outside this record’s scope.
At what content is Retinyl Palmitate notified in Korea?
The notified content is 10,000 IU/g, in lotion, liquid, cream, and sheet-mask (침적 마스크) product forms.